News

However, beneath this success lies a growing concern: the sustainability of this growth trajectory, particularly as ...
The market for drugs that encourage the immune system to attack tumors could explode in the next three years, leading Bristol ...
In the latest episode of The Top Line podcast, host Heath Clendenning interviews Cheryl Lubbert, CEO of Reverba Global, to ...
In a recent interview with Fierce, Brie Thomas, senior vice president of sales at Swoop, shared insights on the dramati | ...
But this doesn’t mean that any alternative is necessarily better. Some are proving to be demonstrably worse. J. D. Vance ...
A Philadelphia founder has been using artificial intelligence for life sciences materials since 2015, long before the mainstream hype for the tech.
Using social media as a pharma brand can feel risky due to regulatory constraints - but it can make a big impact when used in ...
The tariffs that President Trump is considering for national security purposes will, ironically, create the same access and ...
Advanz Pharma secures exclusive rights from Alvotech to commercialize three biosimilar candidates in Europe in addition to previously partnered programsThe agreement includes proposed biosimilars to ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...